NCT06003283View on ClinicalTrials.gov

Tapering of Rituximab Based on Interval Prolongation Compared to Disease Activity-guided Dose Reduction in Patients With Rheumatoid Arthritis

PHASE4RecruitingINTERVENTIONAL
Enrollment

134

Participants

Timeline

Start Date

January 9, 2024

Primary Completion Date

December 31, 2027

Study Completion Date

December 31, 2027

Conditions
Rheumatoid Arthritis
Interventions
DRUG

Rituximab

IV rituximab

Trial Locations (7)

1000

NOT_YET_RECRUITING

Cliniques Universitaires Saint-Luc Bruxelles, Brussels

2170

NOT_YET_RECRUITING

ZNA Jan Palfijn, Merksem

3000

RECRUITING

RZ Heilig Hart, Leuven

RECRUITING

University Hospitals Leuven (UZ Leuven), Leuven

3600

RECRUITING

Reumacentrum Genk, Genk

RECRUITING

ReumaClinic Genk, Genk

9300

RECRUITING

OLV Aalst, Aalst

All Listed Sponsors
collaborator

Fonds voor Wetenschappelijk Reumaonderzoek (FWRO)

UNKNOWN

lead

Universitaire Ziekenhuizen KU Leuven

OTHER